Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense
Yi Yue, Yuqing Ren, Chunya Lu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Development of a prognostic model for muscle-invasive bladder cancer using glutamine metabolism
Sida Hao, Lin Shen, Pengju Liu, et al.
Computers in Biology and Medicine (2024) Vol. 171, pp. 108223-108223
Open Access | Times Cited: 4
LncRNAs act as modulators of macrophages within the tumor microenvironment
Kangning Li, Tao Xie, Yong Li, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 363-377
Closed Access | Times Cited: 4
Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation
Zhilong Yu, Chenyi Wang, Yingjiang Ye, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Novel Photo‐STING Agonists Delivered by Erythrocyte Efferocytosis‐Mimicking Pattern to Repolarize Tumor‐Associated Macrophages for Boosting Anticancer Immunotherapy
Zhiyan Li, Xianghui Li, Yanjun Lu, et al.
Advanced Materials (2024) Vol. 36, Iss. 47
Open Access | Times Cited: 4
A large histological images dataset of gastric cancer with tumour microenvironment annotation for AI
Shenghan Lou, Jianxin Ji, Huiying Li, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access
SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
Pengzhou Kong, Jiao Ye, Meng Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer
Zhou Wei, Zhenzhen Kou, Yun Luo, et al.
Medicine (2025) Vol. 104, Iss. 7, pp. e41578-e41578
Open Access
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
Role of Soluble Cytokine Receptors in Gastric Cancer Development and Chemoresistance
Francesco Severini, Geppino Falco, Tiziana Notarangelo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2534-2534
Open Access
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Exosomes derived from natural killer cells: transforming immunotherapy for aggressive breast cancer
Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, Muhammad Afzal, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Head and neck cancers: Current status preclinical research
Pralhad Wangikar, M. Sandhya, Pradhnya Choudhari, et al.
Elsevier eBooks (2025), pp. 69-94
Closed Access
Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway
Yuanyuan Zhang, Weiwei Jin, Zhichao Deng, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: A systematic review and meta-analysis
F. Albano, Francesco Severini, Giovanni Calice, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167821-167821
Open Access
Tumor Microenvironment: A Complex Landscape of Cancer Development and Drug Resistance
Sohaila Fatima
Cureus (2025)
Open Access
Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC)
Rakesh Kumar, Kamal Jain, Shashi Raj K, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Multiple instance learning-based prediction of programmed death-ligand 1 (PD-L1) expression from hematoxylin and eosin (H&E)-stained histopathological images in breast cancer
Zhen Da, Heng Yang, ZHAXI BIANBA, et al.
PeerJ (2025) Vol. 13, pp. e19201-e19201
Open Access
Exploring the Role of T‐Cell Metabolism in Modulating Immunotherapy Efficacy for Non‐Small Cell Lung Cancer Based on Clustering
Hua Guo, Liangyu Zhang, Tang Hu, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Differences in Tumor‐Infiltrating Lymphocyte Counts in the Peritumoral Area in Patients Undergoing Hepatic Resection After Lenvatinib and Atezolizumab Plus Bevacizumab Therapy for Hepatocellular Carcinoma
Katsuya Toshida, Shinji Itoh, Yasushi Tanaka, et al.
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Mechanistic insights into resistance mechanisms to T cell engagers
Liping Cao, Gabrielle Leclercq-Cohen, Christian Klein, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Metabolic reprogramming involves in transition of activated/resting CD4+ memory T cells and prognosis of gastric cancer
Yue Sun, Li Liu, Yuanyuan Fu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Scroll to top